Recurrent Diarrhea: Causes and Differential Diagnosis
Immediate Clinical Triage
Patients with recurrent diarrhea require immediate physician evaluation if they are elderly (>75 years), have concomitant significant systemic illnesses, chronic bowel disease, or are frail, rather than attempting self-management. 1
Red Flag Symptoms Requiring Urgent Gastroenterology Referral
- Blood in stool 2
- Unintentional weight loss 2
- Clinical and laboratory signs of anemia 2
- Palpable abdominal mass 2
- High fever (>38.5°C) 1
- Severe vomiting leading to rapid dehydration 1
- Obvious dehydration 1
Infectious Causes
Bacterial Pathogens
- Clostridium difficile is of increasing concern, particularly in patients with recent antimicrobial therapy 3
- Recurrent C. difficile infection (≥2 episodes) warrants fecal microbiota-based therapies after completing standard antibiotics 1
- Important bacterial causes include Salmonella, Shigella, Yersinia, Campylobacter, and pathogenic E. coli strains 3
- Enteroaggregative E. coli can cause persistent symptoms 4
- Yersinia, Plesiomonas, and Aeromonas are rare bacterial causes of chronic diarrhea in immunocompetent individuals 5
Viral Pathogens
- Norovirus is the most common cause of diarrheal disease outbreaks and acute gastroenteritis across all age groups 3
- Chronic and severe norovirus infection occurs in immunosuppressed patients following organ transplantation 3
Parasitic Pathogens
- Common parasites causing recurrent diarrhea include Giardia, Cryptosporidium, and Entamoeba histolytica 3
- Approximately 10% of traveler's diarrhea is parasitic, persisting for weeks to months, with giardiasis being most common 3
- Cyclospora and Cystoisospora are additional parasitic causes 3
- Critical pitfall: Standard ova and parasite testing often excludes Cryptosporidium and Cyclospora—clinicians must specifically request these tests 3
Non-Infectious Causes
Gastrointestinal Disorders
- Irritable bowel syndrome with diarrhea (IBS-D) is a common functional disorder requiring Rome III criteria for diagnosis 6
- Inflammatory bowel disease (Crohn's disease, ulcerative colitis) can present with recurrent diarrhea 7
- Post-infectious irritable bowel syndrome can develop after infectious diarrhea 1
- "Brainerd-type" diarrhea can be triggered by infectious episodes 5
Malabsorption Syndromes
- Celiac disease is the most common small bowel enteropathy in Western populations, frequently presenting with steatorrhea (pale, bulky, malodorous stools) 3, 7
- Chronic pancreatitis is the primary cause of severe steatorrhea, requiring approximately 90% destruction of pancreatic tissue before symptoms appear, with fecal fat >13 g/day 3, 7
- Bile acid malabsorption produces diarrhea characteristically occurring after meals and responding to fasting, particularly common after terminal ileum resection or cholecystectomy 3, 7
Endocrine Causes
- Hyperthyroidism causes diarrhea through endocrine effects on gut motility 3, 7
- Diabetes mellitus causes diarrhea via multiple mechanisms: autonomic neuropathy, bacterial overgrowth, bile acid malabsorption, and medication effects 3, 7
Medication-Related
- Adverse effects of antiretroviral therapy or chemotherapy may account for persistent diarrhea in immunocompromised hosts 3
- Medications including magnesium-containing products, NSAIDs, antibiotics, and antiarrhythmics account for up to 4% of chronic diarrhea cases 7
Special Populations
Immunocompromised Patients
- HIV-infected patients are at risk for enteroaggregative E. coli, Cryptosporidium, microsporidia, Cystoisospora belli, CMV, and Mycobacterium avium complex 3
- Diarrhea caused by Cryptosporidium, Cyclospora, Cystoisospora, or microsporidia is more likely to be severe, chronic, or relapsing in patients with impaired cell-mediated immunity 3
- In patients with diarrhea lasting ≥30 days, HIV testing may be appropriate 3
High-Risk Groups for Specific Pathogens
- Risk factors for invasive nontyphoidal Salmonella include young and advanced age, HIV infection, cytotoxic chemotherapy, malnutrition, hemoglobinopathies, recent malaria, and cirrhosis 3
- Yersinia enterocolitica higher risk groups include young African American and Asian children, diabetics, and those with chronic liver disease, malnutrition, or iron-overload states 3
- Vibrio vulnificus infections occur in patients with chronic liver disease, iron overload states, or other immunocompromising conditions 3
Diagnostic Approach
When to Test
Perform selective fecal studies in patients with: 1
- Signs of severe dehydration 1
- Bloody stools 1
- Persistent fever 1
- Immunodeficiencies or immunosuppressive therapy 1
- Suspected nosocomial infection 1
Diagnostic Testing Options
- Culture-dependent methods for bacterial pathogens 4
- Culture-independent methods including PCR and multiplex PCR for bacterial, viral, and protozoal infections 4
- Microscopy for protozoal infections 4
- Pitfall: Multipathogen nucleic acid amplification tests can detect multiple pathogens simultaneously, but the clinical significance of detecting multiple pathogens or nucleic acid alone (versus viable organisms) remains unclear 3
- Fecal lactoferrin testing or microscopy for leukocytes can document inflammation in invasive colitis, severe C. difficile colitis, and inflammatory bowel disease 1
Clinical Clues
- Normal vital signs and physical examination despite reported severe symptoms are consistent with factitious diarrhea 3
- Diarrhea alternating with constipation or no response to vancomycin/fidaxomicin suggests alternative diagnoses to C. difficile recurrence 1
Treatment Principles
When NOT to Treat Empirically
- In most people with acute watery diarrhea without recent international travel, empiric antimicrobial therapy is not recommended 1
- Empiric treatment should be avoided in people with persistent watery diarrhea lasting ≥14 days 1
- Asymptomatic contacts should not receive empiric or preventive therapy 1
Supportive Care
- Reduced osmolarity oral rehydration solution (ORS) is first-line therapy for mild to moderate dehydration 1
- Isotonic intravenous fluids (lactated Ringer's, normal saline) should be administered for severe dehydration, shock, altered mental status, or ORS failure 1
- Human milk feeding should be continued throughout the diarrheal episode in infants and children 1
- Resume age-appropriate usual diet during or immediately after rehydration 1
Antimotility Agents
- Antimotility drugs (e.g., loperamide) should NOT be given to children <18 years of age with acute diarrhea 1
- Loperamide may be given to immunocompetent adults with acute watery diarrhea 1
- Antimotility drugs should be avoided with bloody diarrhea or proven Shiga toxin-producing E. coli infection 1
Specific Therapies
- Antimicrobial therapy should be modified or discontinued when a clinically plausible organism is identified 1
- For recurrent C. difficile infection (≥2 episodes), fecal microbiota-based therapies should be given upon completion of standard antibiotics 1
- Rifaximin 550 mg three times daily for 14 days is FDA-approved for IBS-D in adults meeting Rome criteria 6